Pilot Study Investigating the Biodistribution and Potential Diagnostic Ability of 18F FACBC in Patients With Head and Neck, Breast, and Prostate Cancer

Trial Profile

Pilot Study Investigating the Biodistribution and Potential Diagnostic Ability of 18F FACBC in Patients With Head and Neck, Breast, and Prostate Cancer

Completed
Phase of Trial: Phase I

Latest Information Update: 12 Apr 2017

At a glance

  • Drugs Fluciclovine 18F (Primary)
  • Indications Breast cancer; Head and neck cancer; Prostate cancer
  • Focus Diagnostic use
  • Most Recent Events

    • 07 Apr 2017 Status changed from active, no longer recruiting to completed.
    • 04 May 2016 Planned End Date changed from 1 Apr 2016 to 1 Apr 2017.
    • 04 May 2016 Planned primary completion date changed from 1 Apr 2016 to 1 Apr 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top